The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Exploratory phase I study of HF1K16 for the treatment of patients with refractory/recurrent advanced glioma.
 
Ruofan Huang
No Relationships to Disclose
 
Anjie Zheng
Employment - Hangzhou HighField Biopharmaceuticals
Stock and Other Ownership Interests - Hangzhou HighField Biopharmaceuticals
Honoraria - Hangzhou HighField Biopharmaceuticals
Consulting or Advisory Role - Hangzhou HighField Biopharmaceuticals
 
Yuhong Xu
Employment - Hangzhou HighField Biopharmaceuticals
Leadership - Hangzhou HighField Biopharmaceuticals
Stock and Other Ownership Interests - Hangzhou HighField Biopharmaceuticals
Patents, Royalties, Other Intellectual Property - hold several patents, but currently no royalty generated
 
XIAOCHEN ZHANG
No Relationships to Disclose
 
Jinsong Wu
No Relationships to Disclose